Cite
HARVARD Citation
Achtnichts, L. et al. (2023). Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS). BMJ neurology open. 5 (1), p. . [Online].